|
68
|
244
|
4qltB |
Ycp in complex with tripeptidic epoxyketone inhibitor 2 (pr924) |
|
62
|
231
|
4qw6E |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
68
|
250
|
4qvnA |
Ycp beta5-m45v mutant in complex with bortezomib |
|
67
|
240
|
4qz4C |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
65
|
212
|
4qvvK |
Ycp beta5-a49v mutant in complex with bortezomib |
|
61
|
222
|
4qv8L |
Ycp beta5-c52f mutant |
|
65
|
231
|
4qzxE |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
228
|
4qxjM |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
240
|
4qv9C |
Ycp beta5-c63f mutant |
|
61
|
195
|
4qlsJ |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
66
|
242
|
4qz1D |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
233
|
4qw6M |
Ycp beta5-m45v mutant in complex with carfilzomib |
|
69
|
212
|
4quyK |
Ycp beta5-a49s-mutant |
|
63
|
244
|
4r3oA |
Human constitutive 20s proteasome |
|
67
|
250
|
4qwkA |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
72
|
243
|
4qv7F |
Ycp beta5-a50v mutant |
|
60
|
222
|
4qz7L |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
222
|
4qwsH |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
71
|
244
|
4qv7B |
Ycp beta5-a50v mutant |
|
70
|
242
|
4qlqD |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
59
|
222
|
4qvmL |
Ycp beta5-m45a mutant in complex with bortezomib |
|
58
|
204
|
4qwuI |
Ycp beta5-c52f mutant in complex with bortezomib |
|
63
|
241
|
4qv0G |
Ycp beta5-a49t-a50v-double mutant |
|
60
|
196
|
4r18N |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
68
|
250
|
4qwiA |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
71
|
240
|
4qv0C |
Ycp beta5-a49t-a50v-double mutant |
|
56
|
233
|
4r3oB |
Human constitutive 20s proteasome |
|
57
|
222
|
4qz4H |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
242
|
4qvwD |
Ycp beta5-a49s-mutant in complex with bortezomib |
|
65
|
231
|
4qv5E |
Ycp beta5-m45i mutant |
|
68
|
244
|
4qw5B |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
63
|
231
|
4qlsE |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
60
|
196
|
4r00N |
Ycp beta5-c52f mutant in complex with omuralide |
|
57
|
222
|
4qz0H |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
242
|
4qvmD |
Ycp beta5-m45a mutant in complex with bortezomib |
|
63
|
241
|
4quxG |
Ycp beta5-a49t-mutant |
|
59
|
226
|
4r02H |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
65
|
250
|
4qw0A |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
69
|
242
|
4quxD |
Ycp beta5-a49t-mutant |
|
69
|
250
|
4qz3A |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qv5I |
Ycp beta5-m45i mutant |
|
57
|
204
|
4qz7I |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
230
|
4qwkM |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
67
|
212
|
4qvyK |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
65
|
241
|
4qbyG |
Ycp in complex with boc-ala-ala-ala-cho |
|
67
|
242
|
4qz4D |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
233
|
4qwlM |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
68
|
233
|
4qvnM |
Ycp beta5-m45v mutant in complex with bortezomib |
|
64
|
242
|
4qlvD |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
68
|
250
|
4qzwA |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
